Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA 5'-phosphate and 3'-OH ligase 1 (RLIG1) is an ATP-dependent enzyme that catalyzes the ligation of RNA strands containing a 5'-phosphate and a 3'-hydroxyl group, via a three-step nucleotidyl transfer mechanism involving an enzyme-AMP intermediate. RLIG1 is selective for single-stranded RNA substrates, does not seal nicks in DNA-RNA hybrids, and may play a role in RNA repair and integrity, particularly during oxidative stress. Genetic evidence and biochemical studies implicate RLIG1 in tRNA metabolism, especially in the brain, with potential, though not well-characterized, links to human disease[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA 5'-phosphate and 3'-OH ligase 1 (RLIG1).